Comparison of tacrolimus vs. cyclosporine in pediatric hematopoietic stem cell transplantation for thalassemia

Keyphrases

• Pediatric Hematopoietic Stem Cell Transplantation 100%
• Cyclosporine 100%
• Tacrolimus 100%
• Thalassemia 100%
• Graft-versus-host Disease (GvHD) 87%
• Calcineurin Inhibitors 37%
• Nephrotoxicity 37%
• No Significant Difference 25%
• Neurotoxicity 25%
• Graft-versus-host Disease Prophylaxis 25%
• Adverse Effects 12%
• Clinical Situation 12%
• Engraftment Syndrome 12%
• Retrospective Analysis 12%
• Antalya 12%
• Pediatric Patients 12%
• Liver Graft 12%
• January 2017 12%
• Disease Stage 12%
• Venous Disease 12%
• Allogeneic HSCT 12%
• Pediatric HSCT 12%
• CMV Reactivation 12%
• Effective Prevention 12%
• Disease Occurrence 12%
• Graft Rejection 12%

Medicine and Dentistry

• Hematopoietic Stem Cell Transplantation 100%
• Cyclosporine 100%
• Thalassemia 100%
• Tacrolimus 100%
• Graft Versus Host Reaction 87%
• Calcineurin Inhibitor 37%
• Nephrotoxicity 37%
• Acute Graft Versus Host Disease 25%
• Gut 25%
• Neurotoxicity 25%
• Allogeneic Hematopoietic Stem Cell Transplantation 12%
• Engraftment Syndrome 12%
• Liver Graft 12%
• Pediatrics Patient 12%
• Vein Occlusion 12%
• Graft Rejection 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Ciclosporin 100%
• Tacrolimus 100%
• Thalassemia 100%
• Graft Versus Host Reaction 87%
• Nephrotoxicity 37%
• Calcineurin Inhibitor 37%
• Neurotoxicity 25%
• Acute Graft Versus Host Disease 25%
• Engraftment Syndrome 12%
• Vein Occlusion 12%
• Graft Rejection 12%